According to this algorithm, a high Breslow thickness and serum IL‐4 levels in early‐stage melanoma patients are associated with a poor prognosis, whereas GM‐CSF and DCD levels decrease in patients in whom the disease outcome is poor. The gene discussed is IL4; the disease is melanoma.